Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AVAPRITINIB vs AVIBACTAM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

AVAPRITINIB vs AVIBACTAM: Safety Overview

Metric AVAPRITINIB AVIBACTAM
Total FAERS Reports 10,117 195
Deaths Reported 302 52
Death Rate 3.0% 26.7%
Hospitalizations 942 69
Average Patient Age 62.4 yrs 58.1 yrs
% Female Patients 56.5% 34.4%
FDA Approval Date Jan 9, 2020 N/A
Manufacturer Blueprint Medicines Corporation AbbVie Inc.
Route ORAL INTRAVENOUS
Marketing Status Prescription N/A